142 related articles for article (PubMed ID: 1802958)
1. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.
Panda SK; Ramesh R; Rao KV; Gupta A; Zuckerman AJ; Nayak NC
J Med Virol; 1991 Dec; 35(4):297-302. PubMed ID: 1802958
[TBL] [Abstract][Full Text] [Related]
2. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
3. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
[TBL] [Abstract][Full Text] [Related]
5. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers.
Lo KJ; Lee SD; Tsai YT; Wu TC; Chan CY; Chen GH; Yeh CL
Hepatology; 1988; 8(6):1647-50. PubMed ID: 3192179
[TBL] [Abstract][Full Text] [Related]
6. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
[TBL] [Abstract][Full Text] [Related]
7. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
Wong VC; Ip HM; Reesink HW; Lelie PN; Reerink-Brongers EE; Yeung CY; Ma HK
Lancet; 1984 Apr; 1(8383):921-6. PubMed ID: 6143868
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Chitinand S; Sakulramrung R; Tannirundorn Y
Vaccine; 1990 Mar; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
[TBL] [Abstract][Full Text] [Related]
11. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers.
Young BW; Lee SS; Lim WL; Yeoh EK
J Viral Hepat; 2003 Jan; 10(1):23-30. PubMed ID: 12558908
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.
Velu V; Nandakumar S; Shanmugam S; Jadhav SS; Kulkarni PS; Thyagarajan SP
World J Gastroenterol; 2007 Jun; 13(22):3084-9. PubMed ID: 17589924
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers.
Yeoh EK; Chang WK; Ip P; Chan KH; Chan E; Fung C
J Infect; 1986 Jul; 13 Suppl A():15-8. PubMed ID: 2943811
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.
Lee PI; Lee CY; Huang LM; Chang MH
J Pediatr; 1995 May; 126(5 Pt 1):716-21. PubMed ID: 7751994
[TBL] [Abstract][Full Text] [Related]
17. Prevention of vertical transmission of hepatitis B virus by yeast recombinant hepatitis B vaccine.
Murata R; Isshiki G; Yoshioka H; Chiba Y; Tada H; Koike M; Kimura M
Acta Paediatr Jpn; 1989 Apr; 31(2):180-5. PubMed ID: 2516698
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
[TBL] [Abstract][Full Text] [Related]
19. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
[TBL] [Abstract][Full Text] [Related]
20. Effects of booster HB vaccine in preventing hepatitis B virus infection from mother to child.
Kunitomi T; Ikeda M; Oda M; Yamada G; Eguchi K; Ubuka K; Morita H; Kurashige T
Acta Paediatr Jpn; 1989 Dec; 31(6):669-73. PubMed ID: 2533789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
